Podcasts about cronos group

The Cronos Group CEO Michael Gorenstein joined Steve Darling from Proactive to announce the company's latest product innovations, perfectly timed for the summer season. The portfolio expansion features new flavors and formats from Cronos' award-winning and best-selling cannabis products, including SOURZ by Spinach® edibles and a premier milled flower product. Gorenstein shared that the new SOURZ by Spinach® Fully Blasted gummies deliver the same great-tasting flavors, now with an increased potency of 10 mg of THC per piece. The SOURZ by Spinach® Tropical Party Pack introduces new gummies with bolder tropical flavors, molded in the distinctive Spinach® “S” shape. These gummies offer a perfect blend of sour and sweet, utilizing Cronos' proprietary flavor-masking technology. The SOURZ by Spinach® Fully Blasted line includes one 10 mg THC gummy per package in the following flavors as Pink Lemonade, Blue Raspberry Watermelon, and Electric Blue Raspberry In addition to the new gummies, the Spinach® brand will also introduce Spinach Grindz™, a ready-to-use milled flower product designed for joints or vaporizers. The ready-to-use milled flower offerings have seen a surge in popularity in the Canadian cannabis market, appealing to value-conscious consumers seeking convenience. Spinach Grindz™ caters to this growing demand by providing high-quality, milled cannabis that saves time and effort, ensuring a consistent and hassle-free cannabis experience. Gorenstein emphasized the company's commitment to innovation and meeting consumer needs, noting that these new products are designed to enhance the summer experience for cannabis users. With the introduction of these new edibles and milled flower options, Cronos Group continues to solidify its position as a leader in the cannabis industry, offering premium products that cater to a wide range of preferences and lifestyles. #proactiveinvestors #cronosgroupinc #nasdaq #cron #tsx #cron #GlobalCannabis, #MikeGorenstein, #SpinachBrand, #NewFlavours, #GrowCo, #CannabisInnovation, #CannabisIndustry, #ProductLaunch, #CannabisProducts, #CanadaCannabis, #IsraelCannabis, #GermanyCannabis, #UKCannabis, #AustraliaCannabis, #CannabisMarket, #CannabisGrowth, #CannabisPartnership,#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Cannabis-Aktien wie Aurora Cannabis, Tilray Brands, Canopy Growth, The Cronos Group und noch einige mehr sind in den letzten Jahren deutlich gefallen - teilweise um weit mehr als 90%. Gleichzeitig wird Cannabis aber in immer mehr und durchaus interessanten Märkten legalisiert, auch in Deutschland. Ist das jetzt eine potenzielle Kaufchance: ja oder nein? Meine Meinung dazu in der heutigen Podcastfolge.
 ► Den neuen Podcast “Buy The Dip” findet ihr hier: https://buythedip.podigee.io
 ► Jetzt unseren Buy The Dip YouTube-Kanal abonnieren: https://www.youtube.com/@BuyTheDipPodcast?sub_confirmation=1
 ► Schau Dir hier die neue Aktion der Rendite-Spezialisten an: https://www.rendite-spezialisten.de/aktion
 ► TIPP: Sichere Dir wöchentlich meine Tipps zu Gold, Aktien, ETFs & Co. – 100% gratis: https://erichsen-report.de/
 Viel Freude beim Anhören. Über eine Bewertung und einen Kommentar freue ich mich sehr. Jede Bewertung ist wichtig. Denn sie hilft dabei, den Podcast bekannter zu machen. Damit noch mehr Menschen verstehen, wie sie ihr Geld mit Rendite anlegen können.
 ► Mein YouTube-Kanal: http://youtube.com/ErichsenGeld
 ► Folge meinem LinkedIn-Account: https://www.linkedin.com/in/erichsenlars/
 ► Folge mir bei Facebook: https://www.facebook.com/ErichsenGeld/
 ► Folge meinem Instagram-Account: https://www.instagram.com/erichsenlars
 Quelle der Audio-Snippets, abgerufen am 28.02.2024: URL: https://www.youtube.com/watch?v=LAzuxm8wywY Titel: DEUTSCHLAND: Cannabis-Legalisierung! Was ab 1. April erlaubt sein soll – und was nicht YouTube-Kanal: WELT Nachrichtensender Die verwendete Musik wurde unter www.soundtaxi.net lizensiert.
 Ein wichtiger abschließender Hinweis: Aus rechtlichen Gründen darf ich keine individuelle Einzelberatung geben. Meine geäußerte Meinung stellt keinerlei Aufforderung zum Handeln dar. Sie ist keine Aufforderung zum Kauf oder Verkauf von Wertpapieren.
 Offenlegung wegen möglicher Interessenkonflikte: Die Autoren sind in den folgenden besprochenen Wertpapieren bzw. Basiswerten zum Zeitpunkt der Veröffentlichung investiert:-

Natürlich ist der eigentlich große, fette Aufreger der Woche, dass es die Ratingagentur Fitch tatsächlich gewagt hat, die Supermacht USA wegen der präkären Haushaltslage von „Triple A“ auf „AA+“ herabzustufen und damit die Aktienmärkte weltweit auf Talfahrt zu schicken. Mit dem unvermeidbaren, längst überfälligen Schelte für die USA befasste sich allerdings schon die gestrige Börsenminute und es wird erneut ein Thema in der neuen Podcastfolge der GELDMEISTERIN am Sonntag mit Thomas Mayer sein, Ökonom und Gründer des Research Institutes der Fondsgesellschaft Flossbach von Storch. Was diese Woche noch aufregte, obwohl ihm nachgesagt wird, das es beruhigt ist Cannabis. Es klang verlockend: Juicy Fields, ein Cannabis-Growdgrowing-Projekt in der Steiermark. Tatsächlich ist das vermeintlich lukrative Investment, so warnt die österreichische Wirtschafts- und Korruptionsanwaltschaft, nur Rauch und Schall und soll Anlegergelder von rund 400 Millionen Euro verbrannt haben. Ein ähnlich Anlagebetrugs-Verdachtfall, „My first plant“ wird in Kärnten nachgegangen. Hier besteht auch noch der Verdacht der Geldwäsche. Betroffen sind nicht nur tausende geblendete Investoren in Österreich, sondern weltweit. Ihnen wurden auf wohlgestalteten Internetseiten ertragreiche Investments in den Anbau und Verkauf von medizinischen Cannabis- und CBD-Produkten versprochen. Es besteht der Verdacht, dass ein Großteil der Gelder nie investiert wurde, wobei natürlich für alle Beteiligten die Unschuldsvermutung gilt. Mein alter Freund, Promi-Investor Jim Rogers, erzählt im Podcast GELDMEISTERIN im Vorjahr, dass er auch in einer Cannabis-Plantage für medizinische Produkte direkt in Kolumbien investiert sei. Versteht mich nicht falsch, daran ist nichts Anrüchiges. Nur ich würde es nicht tun. Und das gar nicht einmal, weil ich keine Freundin von Cannabis für den nichtmedizinischen Gebrauch bin, sondern weil mir die Cannabis-Aktien einfach zu heiß sind. Alleine deshalb schon, weil sie vom staatlichen Goodwill der Legalisierung abhängen. Wenn, dann würde ich mich wirklich nur an die großen Player investieren wie die Cronos Group mit einer Marktkapitalisierung von knapp 600 Millionen Euro, in die 2019 auch der US-Tabakkonzern Altria einstieg, oder in die kanadischen Platzhirschen wie Tilray (rund 870 Millionen Euro Marktkapitalisierung), Canopy Growth (Börsenwert über 270 Millionen Euro) oder die populäre Aurora Cannabis-Aktie (181 Millionen Euro Marktkapitalisierung). Es werden auch Cannabis-Aktien-Index gehandelt und es gibt mit Cannabis-Reit eigene Cannabis-Immobilienakten. Solche Spezialindizes und -Fonds bergen für mich zu viel Klumpenrisiko. Da würde ich mich persönlich schon mit einer Pfizer-Aktie, die mit Arena Pharmaceuticals auch einen medizinischen Cannabis-Produzenten in ihrer Gruppe an, wohler und breiter aufgestellt fühlen. Aber wie gesagt, für mich muss es kein Cannabis-Investment sein, da gibt es noch so viel anderen spannende Sektoren, zu denen aktuell offensichtlich nicht die Immobilien zählen. Mehr dazu in der aktuellen Podcast-Folge der Geldmeisterin am kommenden Sonntag. Ich hoffe wir hören uns. Ein schönes Wochenende wünscht Julia Kistner Rechtshinweis: Dies ist die Meinunung der Autorin und keine Anlageempfehlung. Was ihr daraus macht ist Eure Sache, Julia Kistner übernimmt hierfür keine Haftung. #investieren #Cannabis #Anlagebetrug #podcast Foto: Unsplash/Desighecologist

The Daily Business and Finance News Show - Thursday, 6 July 2023 Today's headlines: Instagram launches 'Twitter killer' Threads text app Meta sinks as Wall Street weighs in on Threads launch (update) Nasdaq, S&P, Dow end lower on rate concerns, jobs data; focus turns to payroll numbers Treasury yields spike; US2Y jumped above 5% and the US10Y climbed above 4% Austin is becoming ground zero for autonomous driving tests Twitter threatens to sue Meta Platforms over Threads launch Ford trades lower after reporting Q2 U.S. sales Simon Property raised to Outperform at Wolfe, calling it a 'cash engine' Exxon sees lower natural gas prices, refining margins slashing Q2 earnings Joby Aviation extends rally as FAA certification process advances Mullen Automotive announces $25M stock repurchase program UBS says stocks look too optimistic after the Fed minutes and the idea of a soft landing OPEC is looking to recruit new members to oil producer alliance Cronos Group seesaws amid report of takeover interest BofA highlights July's top 10 growth and value stocks Long-term mortgage rates rise to their highest level in 2023 Explanations from OpenAI ChatGPT API with proprietary prompts. This podcast is produced by Klassic Studios Learn more about your ad choices. Visit megaphone.fm/adchoices

This week in Cannabis Legalization News, the US Cannabis Council (USCC) launched a new super PAC called Legalize America on June 28, 2023. The super PAC is the first of its kind in the cannabis industry, and it is funded by a coalition of leading cannabis companies and advocacy groups. Legalize America's goal is to end the federal prohibition of cannabis and advance reform at the state and local levels. The super PAC will focus on a number of areas, including: Public education: Legalize America will work to educate the public about the benefits of cannabis legalization and the harms of prohibition. Advocacy: Legalize America will advocate for cannabis reform at the federal, state, and local levels. Grassroots organizing: Legalize America will organize grassroots support for cannabis reform. Electioneering: Legalize America will support candidates who are committed to cannabis reform. The launch of Legalize America is a significant development in the fight for cannabis reform. The super PAC has the potential to raise a significant amount of money and to mobilize a large number of voters. If successful, Legalize America could help to end the War on Drugs and to create a more just and equitable cannabis industry. Here are some additional details about Legalize America: The super PAC is chaired by Matt Harrell, vice president of government relations for Curaleaf. The secretary of the super PAC is Pete Meachum, vice president for government relations for Cronos Group. Legalize America has a budget of $10 million. The super PAC plans to focus its efforts on the 2024 elections. Legalize America is a sign of the growing momentum for cannabis reform in the United States. With the super PAC's work, it is possible that we will see federal legalization in the near future. Check out this story and others that topped our list of the week's biggest news. Don't forget to hit like and subscribe for more cannabis legalization content! #cannabisreform #cannabislegalization #cannabisbusiness

In der heutigen Folge „Alles auf Aktien“ sprechen die Finanzjournalisten Laurin Meyer und Holger Zschäpitz über einen Tiefschlag für Merck, berauschende Zahlen beim Luxusgiganten LVMH und fallende Kiffer-Aktien. Außerdem geht es um American Airlines, SynBiotic, Global X Cannabis ETF (WKN: A3DN58), Canopy Growth, Aurora, Tilray, Cronos Group, Rize Medical Cannabis ETF, Life Sciences ETF (WKN: A2PX6U), HanETF Medical Cannabis and Wellness (WKN: A2PPE8), Volkswagen, Ford, Stellantis, iShares MSCI Canada ETF (WKN: A0YEDS), UBS MSCI Canada ETF (WKN: A0X97V), HSBC MSCI Canada ETF (WKN: A1JHYS), Ossiam Bloomberg Canada PAB ETF (WKN: A3DP6J), Barrick Gold, Agnico Eagle, Teck Resources, Patriot Battery Metals, First Quantum Minerals und Austal. Wir freuen uns über Feedback an aaa@welt.de. Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Lawrence Hudson Jr is a Government Affairs Associate with Cronos Group, a globally diversified and vertically integrated cannabis company with a presence across four continents. Lawrence received his JD from Howard University School of Law. He also holds a Master's Degree in Television, Radio and Film from the S.I. Newhouse School of Public Communications at Syracuse University and BS in Criminal Justice from with a Minor in Public Relations from St. John's University. He is a member of Kappa Alpha Psi Fraternity, Inc and hails from Queens New York. To learn more about Cronos Group visit www.thecronosgroup.com --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/cannabisdiversity/message Support this podcast: https://anchor.fm/cannabisdiversity/support

Elke Kraemer is al meer dan 25 jaar actief in de techsector in verschillende managementfuncties. Wat haar echt definieert is dat ze gepassioneerd is door projecten die mensen inspireren om anders naar onze wereld te kijken. Met Clusity wil ze vrouwen inspireren om te doen wat ze willen en zich niet te laten tegenhouden door stereotypen. Ze wil mensen inspireren om diversiteit te omarmen als een motor voor innovatie. Omdat ze gelooft dat een bedrijf innovatiever en duurzamer wordt als het een afspiegeling is van de diverse samenleving waarin we leven. "Het is gunstiger om op te vallen dan om op iedereen te lijken en op te gaan in de massa. Je wilt een USP hebben, iets gedenkwaardigs, een indruk achterlaten, zodat mensen weten waar je voor staat." Als startpunt richten ze zich op genderdiversiteit binnen de Cronos Group, waar Clusity onderdeel van uitmaakt. Ze bieden daarvoor een inspirerend netwerk, workshops, events en carrièremogelijkheiden om ervoor te zorgen dat meer vrouwen bij het bedrijf komen, groeien en erbij horen. Dit door middelen van rolmodellen, een community, evenementen en workshops. Here's where we talked about: Elke's definitie van Work Fashion Dressing with a purpose Stereotiepen en rolmodellen Agile dressing Summary Here you can read the summary of the podcast in English: https://the-acquired.com/blogs/podcast/elke-kraemer Connect with us: LinkedIn Elke: https://www.linkedin.com/in/elkekraemer/ LinkedIn Lynn: https://www.linkedin.com/in/lynn-mikolajczak/ The Acquired: the-acquired.com IG: @the_acquired

Second quarter 2021 earnings call for Cronos Group Inc. For further information, please consult the company website at http://www.thecronosgroup.com/Support this podcast at — https://redcircle.com/tsx-quarterly/exclusive-contentAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Why Listen: Well, my guest today is an absolute Rockstar. There's a couple of reasons to listen. First of all, he started his career in marketing. He has been at the helm of very senior companies, including Kraft Foods, Wrigley, Novartis, Nestle, The Blue Buffalo Company. He's on the board of Campbell Soup. He took Blue Buffalo public. He was the head of Gerber when it was acquired by Nestle. He has an incredible history, and part of his advice is just focusing on the job in front of you, not having a sense of where you want to go. But not planning out every step and just knocking out of the park whatever job you're working on, tons to learn from his description of his previous jobs. His current role is at the Chronos Group, which is in the cannabis space, they do 50 million in sales, 1.2 billion in cash. It really speaks to the credibility of this as an industry, why veterans may consider it as a career path. And just hearing what it's like after decades of being at the helm of very large companies. What it's like to take a more entrepreneurial twist and be at the helm of a very, very, relatively small company.  About Kurt: Kurt is now the CEO of the Cronos Group, which is an innovative global cannabinoid company with international production and distribution across five different continents. Since graduating from the Naval Academy, he has held senior positions at Kraft Foods, Wrigley, Novartis, Nestle, The Blue Buffalo Company, and Campbell Soup Company. He holds an MBA from the University of Chicago, and Kurt spent 14 years working internationally in Germany, Hungary, Switzerland, and Australia.

EPISODE SUMMARY: This is the most meaningful interview our team has done to date. We flew to Boston, MA to visit Ginkgo Bioworks, a disruptive new company leading the way in synthetic bioengineering. We toured their foundry and interviewed both Jason Kelly, Co-Founder & CEO, and Anna Marie Wagner, SVP Corporate Development. We encourage everyone to investing the time watching this entire video, and using the quick-links below to navigate to different segments of the interview. 00:50 - What is Synthetic Biology? "What do we want biology to do to make our lives better?" 02:50 - How is Ginkgo Bioworks disruptive? What industries / sectors are ripe for disruption? - The way Ginkgo see the world: building programmable platform to develop biology for all markets. 05:37 - Business model is just like a mobile app store of which people develop apps on -same thing, just instead of apps, its live cells. 06:35 - Why Ginkgo is misunderstood + history of the word 'biotech' and how people associate it only with pharmaceuticals when it should be understood as programming organisms 09:45 - How is DNA programmable? 12:30 - Solving vital problems in the world (great examples of how massive industries like pesticides are being disrupted) 16:10 - Impossible Burger explained + market opportunity 18:01 - Enabling Ginkgo customers to develop solutions for everyday problems + Motif Foodworks, a Ginkgo subsidiary company, explained (https://madewithmotif.com/) 19:49 - Covid 19: What role has Ginkgo Bioworks played during the pandemic, and how has the company adapted to meet the needs of our new way of living? 22:52 - Breaking down the economics of synthetic biology + how automation is essential for Ginkgo's operation 27:40 - Incubator for start-ups and entrepreneurs to build biotech businesses on the Ginkgo platform (mentorship & access to the platform in exchange for equity) 29:30 - Project pipeline overview (500 projects, 500 streams of revenue) 30:54 - Strategic parter: Cronos Group (cannabis) explained 33:00 - Government projects PODCAST CHANNELS: Spotify: https://bit.ly/Disrupting-Spotify Apple: https://bit.ly/Disrupting-Apple Google: https://bit.ly/Disrupting-Google PODCAST HOSTS: Alex Cutler | https://twitter.com/AlexCutler247 Dana Donovick | https://twitter.com/DanaDonovick FOLLOW & CONNECT: https://facebook.com/Disrupting https://instagram.com/Disrupting_ https://twitter.com/Disrupting_ PRODUCTION: Dana Donovick, Passion Possible, LLC. dana@passionpossible.com • 206-222-0740 Legal Disclosure: Disrupting Media (company) and its host are not financial advisors. The information contained in this video is for entertainment purposes only. Before investing, please consult a licensed professional. All content distributed by Disrupting Media (company) and its host IS NOT to be considered as investment recommendations or guidance in any form. Disrupting Media (company) and its host are NOT held liable for any losses you may incur for investing and trading in the stock market. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/disrupting/message Support this podcast: https://anchor.fm/disrupting/support

First quarter 2021 earnings call for Cronos Group Inc. For further information, please consult the company website at http://www.thecronosgroup.com/ Support this podcast at — https://redcircle.com/tsx-quarterly/exclusive-content Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

Fourth quarter 2020 earnings call for Cronos Group Inc. For further information, please consult the company website at http://www.thecronosgroup.com/ Support this podcast at — https://redcircle.com/tsx-quarterly/exclusive-content Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

The Cannabis 101 Podcast is your guide through the legalization and consumption of cannabis in Canada and beyond. It's not just about getting high, it's about getting healthy. Catch Hour One on Monday and Hour two on Wednesday.  Along with products that get you high, there are a lot of great products out there that can help with aches and pains as well as relax you, like Bath Bombs. This week I welcomed Tanner Stewart of Stewart Farms out of New Brunswick who have Bath Bombs on the market in their home province as well as in Alberta. We discussed their growing process and how it involves fish!!! Plus why the packaging was so important to Tanner and Mother Earth and why they chose the three cultivars they went with. We also discussed the current market and what's next? We'll have One Hitters with Tanner on the weekend.  Chris Ianson is our educator and a Regional Manager with Plantlife Cannabis. Each week we explore a different cultivar and make recommendations for what level of cannabis user it fits with based on their level of experience. From the LP Cove we looked at Reflect (Chemdawg Tangerine) an indica dominant hybrid. The lineage is very fun to look at and the brand Cove is one of many under the Cronos Group umbrella. A great smell and taste with this one and we'll tell you Who/What/When it's good for.The Cannabis Question is about Christmas gifts and the Cannabis Character is from Pineapple Express. You can hear full episodes and more at www.Cannabis101Podcast.ca where you can sign up for The Weed Weekly and get in on our Friday giveaway, and you can watch full episodes, individual segments and product reviews on our YouTube channel. Thanks to all our partners like Stone Smiths', you can find them here. 

Third quarter 2020 earnings call for Cronos Group Inc. For further information, please consult the company website at http://www.thecronosgroup.com/ Support this podcast at — https://redcircle.com/tsx-quarterly/exclusive-content Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

Second quarter 2020 earnings call for Cronos Group Inc. For further information, please consult the company website at http://www.thecronosgroup.com/ Support this podcast at — https://redcircle.com/tsx-quarterly/exclusive-content Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

First quarter 2020 earnings call for Cronos Group Inc. For further information, please consult the company website at http://www.thecronosgroup.com/ Support this podcast at — https://redcircle.com/tsx-quarterly/exclusive-content Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

Paul Rosen played a key role at the very beginning of the birth of the Canadian cannabis industry. He was a founder of Pharma Can Capital, which is now known as the Cronos Group, one of the earliest huge successes in Canada. Since then he has been one of the most active investors in global cannabis, and a trusted advisor to some of the most powerful companies. Paul’s other cannabis ventures include Tidal Royalty, BreakWater Venture Capital, and Global Go. Unlike a lot of the new suits, Paul has a personal relationship with the plant and has a wealth of knowledge to offer any aspiring cannabis-conscious corporate executive.****Email: paulrosen44@gmail.comhttps://globalgo.consultinghttps://arcviewgroup.com**** Please send all inquiries to RadioFreeCannabis@SteveDeAngelo.com****https://www.libertyclothing.comhttps://homegrowncannabisco.comhttps://shopharborside.comhttps://hempzoo.com****Intro Music: Soul Majestic https://soulmajestic.com/

The ups and downs of the private and public marijuana markets Guest - Paul Rosen, Co-founder at The Cronos Group howardlindzon.com, thecronosgroup.com Twitter: @howardlindzon, @knutjensen

Paul Rosen (CEO of Paul Rosen International, Pantry). Paul is a noted career entrepreneur, management consultant and public speaker. Over the last 7 years, he has become one of the most active entrepreneurs and investors in the emerging global cannabis industry. Paul tells Mike and Mary Jane about how he moved into cannabis entrepreneurship from practicing law, and co-founded PharmaCan Capital (now The Cronos Group). For the first time ever, Paul shares his story of "Dowding" — that is, experiencing an uncomfortably high dose of cannabis, as NY Times columnist Maureen Dowd famously wrote about. He emphasizes cannabis as a wellness product, and Pantry as a food company that uses cannabis, rather than a cannabis company that uses food. Listen in for a conversation with one of the top cannabis entrepreneurs in the world. GIVE US A 5-STAR REVIEW / CHECK OUT HALL OF FLOWERS / FOLLOW YOUR DREAMS Music by Jesse Case Weed+Grub IG Weed+Grub Facebook Pantry Food Co. Hall of Flowers Green Street Smoking Paper

Today the Dow closed about flat, only gaining 36 points after the Fed announced a quarter-point rate cut and Jim Cramer’s breaking down the action. Then, AGCO cruises into CNBC with a monster Combine, and Cramer’s learning about the new hardware and what the future of farming looks like with the Chairman & CEO. And, the cannabis cohort was once red-hot, but now that it has cooled down, is now the time to circle back? Cramer’s getting a read on the space with Cronos Group’s CEO. Plus, Cramer’s taking a look at FedEx and Adobe post-earnings to make sense of the declines. Learn more about your ad choices. Visit megaphone.fm/adchoices

This Week In Marijuana Business News for the week ended May 17, 2019, with host Jill Reddish. Headlines include: ‘Be at the table, or you’re on the plate’: Part 1 of a Q&A with CV Sciences exec Doug Mackay;  ‘Distinct products, distinct plants – that’s the only way’: Part 2 of a Q&A with CV Sciences exec Doug Mackay Don’t expect a major rollout of infused cannabis products in Canada until 2020 In Focus series:  How a little-known tax auditing firm became ‘kingmakers’ of California cannabis Decades of relationships give rise to HdL’s California cannabis stronghold Profit-maker or profiteer? Cannabis industry conflicted on HdL’s influence, impact EU-GMP: TerrAscend achieves milestone; first in a ‘new wave’ for exporters? Chart: Denver-area cannabis sales up 10%-27% in advance of ‘bomb cyclone’ storm Italy’s interior minister declares war on cannabis, but stakeholders expect limited impact Marijuana firm Tilray revenue up nearly 200% in Q1; net loss grows on spending Canadian marijuana firm Aurora’s sales surge, losses widen Cannabis firm Cronos Group misses on revenue, reports wider Q1 loss Acreage to sell cannabis real estate assets to newly formed REIT New Jersey medical cannabis rules to allow separate business permits; Key New Jersey lawmaker gives up on adult-use marijuana legalization for now Licensed medical cannabis delivery services launch in Michigan Maryland medical marijuana dispensaries now allowed to sell edibles; Ohio dispensaries kick off sales of edible medical cannabis products Missouri’s Triad Bank now offering services to cannabis businesses Arkansas medical marijuana sales top $93,000 in first three days; Long-awaited medical marijuana sales begin in Arkansas Subscribe to both of our podcasts on iTunes, Stitcher and here on our site!

This Week In Marijuana Business News for the week ended May 10, 2019, with host Nick Thomas. Headlines include: 5 key takeaways from MJBizDaily’s European Cannabis Symposium CBD giant CV Sciences reports $9 million loss in first quarter Cannabis firm Cronos Group misses on revenue, reports wider Q1 loss Epidiolex, Sativex maker GW Pharmaceuticals reports Q1 revenue, loss improvement Chart: Florida medical cannabis market surges ahead, with five companies dominating Texas House OKs second bill to expand medical marijuana qualifying conditions Alabama Senate moves limited medical marijuana program bill forward Ohio panel endorses anxiety, autism as conditions for medical marijuana use Cannabis business win/loss scorecard in Golden State’s legislative session Schumer to reintroduce federal cannabis reform bill Netherlands prepares legal recreational cannabis cultivation experiment Most state attorneys general back cannabis banking reform; treasurers warming What can cannabis learn from the tech industry? Q&A with ex-Yahoo CEO and current Caliva chair Carol Bartz Subscribe to both of our podcasts on iTunes, Stitcher and here on our site!

NextLeaf Solutions (CSE:OILS) beat multi-billion dollar public companies to the first U.S. patent for the extraction and purification of cannabinoids. The company has a facility in B.C. ready for “Legalization 2.0” to be a white label provider to many different types of consumer facing cannabis companies. Capital Ideas Media publisher Mark Bunting talks to Paul Pedersen, co-founder and CEO of Nextleaf, who was also a founder of Peace Naturals, which was bought by Cronos Group.

Marijuana Today Daily Headlines Monday, March 11, 2019 | Curated by host Shea Gunther // Cancer patient speaks out after police search his room for marijuana (WWLP 22 News) // Altria Takes Control of Cronos Group with C$2.4 Billion Investment (New Cannabis Ventures) // Senators Are Angry That Marijuana Sentences Are Longer Than Paul Manafort’s […]

Marijuana Today Daily Headlines Monday, March 11, 2019 | Curated by host Shea Gunther // Cancer patient speaks out after police search his room for marijuana (WWLP 22 News) // Altria Takes Control of Cronos Group with C$2.4 Billion Investment (New Cannabis Ventures) // Senators Are Angry That Marijuana Sentences Are Longer Than Paul Manafort’s […]

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: Cannvas MedTech (CSE: MTEC) (OTCPK: CANVF), The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) and Cronos Group (NASDAQ: CRON) (TSX: CRON)

In this Best of Episode of Capital Ideas Radio, Mark Bunting talks to Cronos Group (TSX:CRON;NASDAQ:CRON) Chairman, President and CEO Michael Gorenstein about the company's ambitious plans to have cannabis production hubs on six continents. (This episode was recorded in March of 2018.)

And they're off! But before the race begins, how does one increase the odds of picking the right horse? If it was any other plant it wouldn’t be a big deal, but there are mounds of empirical evidence to suggest and to conclude that cannabis can be effective as medicine. Oil based synthetic textiles and big pharma don't benefit if cannabis and hemp fiber thrive - consider it just a matter of how business works rather than just a big conspiracy. Change is coming from the bottom up. A recent poll done in NZ suggests that up to 75% agree that medicinal cannabis should be treated the same as any other medicine - 35% said they would consider taking it for chronic pain. The fact that this tide is turning means there’s an opportunity if you’re an entrepreneur or an investor - there's also plenty of opportunity to get stung too, as evidenced by the recent failure of Medicann, founded in March 2018, now already in liquidation. Certainly, from an overseas perspective, if a player in this space is to make it and thrive, it appears as though there are likely going to be three phases to go through: 1- a bubble phase 2- a re-alignment phase and the 3 - a 'squeeze' phase (when margins tighten and cannabis firms need to refine to thrive). Cannasouth –  a company that aims to be the first medical cannabis company to list on the NZX in mid 2019. Finally, outside of crowdfunding, retail investors can share in some of the excitement to come. Cannasouth is not the first Cannabis company we’ve had on the show (check out episode 11 and 12 - Paul Manning from Helius) and likely won't be the last. Mark is the CEO and Nic is the COO – both have significant experience in business, the hemp industry and now with medical research around Cannabis. Nic and Mark have a strong desire to positively affect society, science and especially the environment. Overseas, Altria Group Inc., the U.S. maker of Marlboro cigarettes, recently made a $1.8 billion investment (45%) in a Canadian company Cronos Group based on a simple premise: Cannabis is growing faster than cigarettes. There are murmurings of soft drink manufacturers getting into this space also – the big players wait for the risk profile to fall before buying in, and if you want a piece of the action now the risk is high – estimated at over $1b per annum for medical cannabis along in NZ right now, there’s rewards for early movers. Are there opportunities for the NZ everyday investor? The trap for investors would be to back all the horses heading to the track – the art will be in determining who the potential winners will be before the race truly begins Thinking back to what previous guests like Lance Wiggs (episode 18), Daniel Kieser (episode 20) and Mike Taylor (episode 25) have all covered: The best advice when investing is to invest in what you’re interested in. Secondly, can you see that its going to become big? Think back to when the Iphone launched in 2007 – the stock price for Apple was about $15 in June 2007 and now it’s about $150 – If you know somethings going to be a game-changer, it's really that simple. So where are we at with the legalities of cannabis - after all, in order for investors to see a real return here, revenue needs to come in, and this can't happen until the full measure of daylight shines on this black market sector. The misuse of drugs act amendment bill aims to pave the way for medicinal cannabis in NZ and the time frame is now 12 months for regulations to be written (public and media pressure are responsible for this). For some it’s not happening fast enough but I personally think there’s wisdom in getting things right from the start. For cannabis companies like Cannasouth its all about execution and timing. Where to find Cannasouth: www.cannasouth.co.nz NZ Everyday Investor Podcast: https://www.facebook.com/NZ-Everyday-Investor-338969376637717/ https://NZEverydayInvestor.com We're keeping it real on NZ Everyday investor - we're not journalists and this isn't an interview - it's a discussion, hosted by someone who's genuinely into this sort of thing. If you like what we do, remember to subscribe to our show and share it with others - we'd really appreciate it! You know what else would be make us rather pleased with ourselves? Write a review on facebook too! Where to find Darcy Ungaro: Ungaro &Co (registered) financial advisers https://www.ungaro.co.nz Facebook: https://www.facebook.com/UFinServ/?ref=bookmarks Instagram: https://www.instagram.com/ungaro.co.nz/ Help support the mission of our show here - help us grow wealth in the lives of everyday Kiwis!

Canopy Growth is the first cannabis company to take advantage of a new path to do business in the U.S. Also, Aurora Cannabis preliminary financials show investors just how significant Canada's recreational market is for the industry, and Cronos Group's recent tie-up with tobacco giant, Altria, puts it in an envy-inspiring position. Stocks: CGC, ACB, CRON, MO, STZ Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn Or, reach us by email @ IndustryFocus@fool.com

Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a 2019 outlook for the sector as the 2018 US Farm Bill law plants the seeds of a new era for the US markets.According to New Frontier Data, quote, “The 2018 Farm Bill will restore industrial hemp to nationwide legal production for the first time since World War II, offering vast opportunities for the industry and investment in a market expected to triple in four years.” End quote.With the removal of hemp from federal prohibition under the Controlled Substances Act of 1970, the total U.S. hemp industry now looks to expand at a healthy 18.4% through a 5-year combined annual growth rate from 2018-2022. New Frontier Data’s Hemp Business Journal estimates that, in leading all hemp product categories, the hemp-derived CBD market will grow from a $390 million-dollar market in 2018, to a $1.3 billion market by 2022, representing a 27.2% 5-year CAGR.SinglePoint, Inc. (OTCQB ticker symbol SING) just stated in recent news, quote, “This is a huge win and opportunity for us. The company’s subsidiary SingleSeed.com is an ecommerce-based business that sells and supplies industrial-based hemp cannabidiol (CBD) products. As hemp has become more mainstream and now a fully federally legal commodity the company plans to add more to its offering. Ranging from Biofuel to construction materials to extracting cannabidiol used to treat various ailments and wellbeing, industrial hemp now has an opportunity to be competitive in the global marketplace. Looking ahead to 2019, SinglePoint management is seeking new deals and currently negotiating potential acquisitions across different sectors and will continue to grow revenue through its acquisition model. Management is confident revenue growth through hemp-based initiatives will be successful through 2019 and beyond,” end quote.Bruce Linton, Chairman & Co-CEO, Canopy Growth Corporation, the world's largest diversified hemp and cannabis company, (CGC on New York Stock Exchange), commented on the passage of the Farm Bill saying, quote, "Canopy Growth commends the United States government for passing the Farm Bill, a transformative piece of legislation that will create jobs and meaningful economic impact across the United States. Thanks to a deep hemp-specific portfolio of intellectual property acquired from Colorado-based ebbu Inc. and a landmark investment of USD $4 billion from Constellation Brands, management believes it is well-positioned to enter the US market quickly.” End quote. Canadian-based Tilray, Inc. (NASDAQ ticker symbol TLRY), a global leader in cannabis research and production said in December following a flurry of deal flow, quote, “The Farm Bill in the U.S. presents an opportunity to enter the hemp-derived CBD industry and capitalize on an estimated US$22 billion market. Tilray has the expertise, team and supply in place to pursue this opportunity and looks forward to potentially expanding its product offerings to include hemp-derived CBD in U.S.” End quote.Another Canadian-based player, with a presence across five continents, Cronos Group (NASDAQ ticker symbol CRON) is on most investors’ watch list following recent news of a C$2.4 billion strategic investment from Altria Group, Inc.Following the news, during the company’s conference call, Graeme Kreindler from Eight Capital asked about Altria’s experience in the US market and how it would play a role. Quote, “So I was wondering if there’s been any discussions about what that could mean for Cronos in the event of a passing of a farm bill here, on a strategic initiative there?” End Quote.Cronos Group’s CEO Mike Gorenstein said, quote, “Sure. I think any market, it’s great being able to draw from that experience. One of the things that we found is going to be really important is the experience that Altria has dealing with agencies like the FDA and making sure that, again, we follow all the steps, we follow the right processes to make sure that we’re bringing products on in a responsible fashion and in collaboration with regulators. So I think that will be very, very important for us.” End quote.With headlines like,’ 'Financial cascade': How the U.S. farm bill could unleash a multi-billion dollar CBD business overnight’ investors are looking to 2019 as a big year for cannabis stocks but as always, are reminded to keep their feet firmly planted in the ground with some due diligence.Material originally published: otcmarkets.com About InvestorIdeas.comThis episode is brought to you via Stock Wave - a production company that provides audio & video services to variety of clients. Stock Wave may have been compensated for the production of this audio service.In trading, there can be no assurance that any prior successes or past results as to income earnings can be used as an indication of future success or results. Audio/video services by Stock Wave are for informational purposes only and do not purport to be a complete study of the featured company or other companies mentioned. Information used and statements of fact have been obtained from the featured company and other sources, but not verified nor guaranteed by Stock Wave, as to completeness or accuracy. Listeners are advised to use caution and seek the advice of qualified professionals before acting on any information provided by Stock Wave’s audio/video services. Listeners are also advised to perform their own due diligence when it comes to making investment decisions.

News and follow-ups from the world of cannabis, including Follow-ups on recent stories out of Utah, Colorado, and DC Maryland medical marijuana sales blowing away projections New York’s governor readying a plan to legalize adult use Two altar boys from Spain pull a prank during mass Marlboro sinking $1.8 billion in Cronos Group and much more Vote Pro Pot-Cast needs your help. Leaving us a comment and/or a 5-Star rating on iTunes, helps Vote Pro Pot-Cast move up in Podcast search engines, increasing our ability to spread the reform advocacy message.  LINKS: NORML Marijuana Policy Project Drug Policy Alliance National Cannabis Industry Association U.S. Capitol Switchboard: (202) 224-3121    You can find all Vote Pro Pot-Cast episodes on most popular podcast directories. Please contact & follow us: VoteProPot.com eMail  (votepropot@gmail.com) Facebook Twitter LinkedIn    INTRO Music: "Slow Burn" Kevin MacLeod (incompetech.com) Licensed under Creative Commons: By Attribution 3.0 http://creativecommons.org/licenses/by/3.0/   Closeout song, "Cannabis Cafe" Written & performed by David Rovics http://www.davidrovics.com/

On BIV Today…  BIV’s tech panel weighs in on the arrest of Huawei’s CFO and whether Uber’s pending IPO will force the company to focus on profit. Linda Fawcus, founder and CEO of Gluu Technology Society, and Progressa CEO Ali Pourdad also discuss how closely your apps may be tracking the details of your life. Tidal Royalty CEO Paul Rosen – co-founder of PharmaCan Capital, now The Cronos Group – shares new insights on Canadian cannabis consumers, and looks ahead to how the legalization of edible products will be an industry game-changer. Hayley Woodin hosts, see more at https://biv.com/

Scott Cecil and first-time guest Jahan Marcu, PhD, join host Dan Goldman to talk about the recent acquisition of Canadian marijuana company Cronos Group by the Altria Group, owners of Marlboro cigarettes, as well as the state of CBD science. Produced by Shea Gunther.

In this weeks episode, The Big Bros sit down to discuss various topics that have been going viral on the “Twitters”. We start off with our thoughts on the new Avengers: Endgame trailer and the reboot of some tv shows. We talk about Blackfishing and the controversy that surrounds some Instagram models who partake in it, what it means to “talk white” and the hyper sensitivity in today's society. We then shift our focus to the cigarette company Marlboro, who have bought a 45% stake in the cannabis company, Cronos Group, which is a gutsy business move that may indicate whether or not the US will be legalizing marijuana soon. Is Blackfishing a real problem? Are there ever such a things as “talking white”? Will we ever go back to not being so hyper-sensitive? Will Marijuana finally be legalized throughout all 50 states and what effects will it have? Let us know your thoughts on those questions.If you have any topic recommendations please feel free to email us at bigbrospodcast@gmail.com or DM us on Instagram/Twitter @bigbrospodcastSocial Media Info:Ayub Instagram: @somalididdy Twitter: @trapshiekhHaji Instagram: @mhaji4Twitter: @_bigbrohajiPlease don’t forget to Rate, Review, Share & Subscribe! Hope you enjoy

Big investment and Big moves for Cannabis company Cronos Group. Found this tweet from CB1 Capital. Are you looking to help support the Simple Eats brand? Click this link: anchor.fm/simpleeats to become a monthly supporter. Simple Eaters I love you all. Lets make this world a healthier place to live. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/SEWCT/support

Mike Gorenstein shares Cronos' goals for expanding reach: "For us it's about creating a global platform, and innovating products so that we can pilot these out, we can get the products in Canada, we can get them into consumers' hands, and we're on five continents now. We can immediately scale them globally."

Another volatile cannabis stock, where multi-timeframe helps avoid whipsaws! $cron $study

Mike Gorenstein, Chairman, President & CEO of Cronos Group, addresses questions regarding Bill C-45, policing of cannabis, average retail price per gram, global market size predictions, consolidation, and more. • About Mike Gorenstein • Michael Gorenstein is the Chairman, President & CEO of Cronos Group. Before joining Cronos, Mr. Gorenstein was a partner at Alphabet Ventures LLC, a multi-strategy investment management firm located in New York City. Prior to Alphabet Management, Michael was the VP and General Counsel of Saiers Capital LLC and a corporate attorney at Sullivan & Cromwell where he focused on Mergers and Acquisitions and Capital Market transactions. Michael graduated from the University of Pennsylvania Law School with a JD, the Wharton School at the University of Pennsylvania with a certificate in BEPP and the Kelley School of Business at Indiana University with a BSB in Finance. Learn more about the Evolve Marijuana ETF (TSX: SEED): https://evolveetfs.com/SEED

This week on #PotStockRadio Eric Butz @PotStockEric and his co-hosts Nick, KD and Sweeney will interview 2 Pot Stock CEO's. First, we talk to Chuck Rifici CEO of Cannabis Wheaton (tickers are CBW on CSE & KWFLF on the OTC). Chuck will discuss what it means to be "the first cannabis streaming company in the world" and how the company is working to change the fundamentals of how Canadian companies invest in marijuana. We'll also talk about Chuck's past and how he became the Willy Wonka of Weed in Canada. In the second hour we'll talk with Mike Gorenstein of Cronos Group (tickers are MJN on TSXV and PRMCF on the OTC). Cronos is a geographically diversified and vertically integrated cannabis group that operates within Health Canada and distributes globally. We'll talk to Mike about Peace Naturals as well as other brands they are invested in.   As always any questions or feedback about the show can be directed to eric@potstockradio.com PotStockRadio does not condone or promote the use of any illegal substance. Also, PotStockRadio is for educational and informational purposes only and is not intended to give financial advice!

SAVE THE DATE BENZINGA CANNABIS CAPITAL CONFERENCEThe premier gathering of cannabis entrepreneurs and investors in North America returns for a 2-Day Hybrid Event on October 14-15.Buy Tickets here!News:BENZINGA EXCLUSIVE: Want To Know The Hottest Brands In Cannabis In 2021? Meet The People Deciding Who They AreMarijuana Money: Rapper Kid Cudi Seeks To Hire A Professional Blunt RollerSchwazze To Buy Colorado Cultivation Grower Brow 2 For $6.7M In CashShould You Buy Trulieve Stock Before Its $2.1B Merger?For more Cannabis Headlines subscribe to Subscribe to our Cannabis Daily PodcastEpisode Summary:Patrick and Javier talk to Michael Gorenstein: Executive Chairman of The Cronos Group about Gummies and other innovative products planned, partial PharmaCann acquisiton and marijuana cigarettes.Related: Cronos Group Acquires 10.5% Ownership Stake In PharmaCann For $110.4MGuests:Michael Gorenstein: Executive Chairman, The Cronos Group 10:00https://thecronosgroup.com/Hosts:Patrick Lanehttps://twitter.com/PatrickLaneBZJavier Hassehttps://www.twitter.com/JavierHasseSubscribe to our Cannabis Daily Podcast for daily Cannabis news and trade ideas.Follow us on Social at https://twitter.com/BZCannabisCheck Out https://www.benzinga.com/cannabis/ for Cannabis And Psychedelics News and Stock PicksGet Notified of future BZ Cannabis Events at https://www.benzinga.com/events/cannabisSubscribe to the Cannabis Insider Newsletter https://share.hsforms.com/1SD_FsDd8TnS-RYQYnORPFw1npzhBenzinga Cannabis Hour is a podcast focused on marijuana and all things weed, CBD, hemp and psychedelics. Hosts include Elliot Lane, Javier Hasse and Patrick Lane.Disclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.Support this podcast at — https://redcircle.com/benzinga-cannabis-hour/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy